Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Guldberg

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Clinical Epigenetics|September 17, 2022
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsHeidi Dietrichson Pharo, Marine Jeanmougin, Eirill Ager-Wick, et al.
Nature Communications|March 8, 2018
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cellsAlexei F Kirkin, Karine N Dzhandzhugazyan, Per Guldberg, et al.
Blood|August 19, 2017
<i>TP53</i> mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapyChristian W Eskelund, Christina Dahl, Jakob W Hansen, et al.
Journal for Immunotherapy of Cancer|March 3, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanomaAlex Frias, Luca Di Leo, Asier Antoranz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanomaLuca Di Leo, Chiara Pagliuca, Ali Kishk, et al.
Nature Communications|September 6, 2024
Hyper-recombination in ribosomal DNA is driven by long-range resection-independent RAD51 accumulationZita Gál, Stavroula Boukoura, Kezia Catharina Oxe, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2025
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibitionMie K Jakobsen, Sofie Traynor, Aaraby Y Nielsen, et al.
Nature Communications|May 6, 2021
Loss of Ambra1 promotes melanoma growth and invasionLuca Di Leo, Valérie Bodemeyer, Francesca M Bosisio, et al.
Molecular & Cellular Proteomics : MCP|July 2, 2003
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer researchJulio E Celis, Pavel Gromov, Irina Gromova, et al.
Human Mutation|March 26, 2003
Genetic diversity within the R408W phenylketonuria mutation lineages in EuropeOrna Tighe, Donncha Dunican, Charles O'Neill, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Clinical Epigenetics|September 17, 2022
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsHeidi Dietrichson Pharo, Marine Jeanmougin, Eirill Ager-Wick, et al.
Nature Communications|March 8, 2018
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cellsAlexei F Kirkin, Karine N Dzhandzhugazyan, Per Guldberg, et al.
Blood|August 19, 2017
<i>TP53</i> mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapyChristian W Eskelund, Christina Dahl, Jakob W Hansen, et al.
Journal for Immunotherapy of Cancer|March 3, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanomaAlex Frias, Luca Di Leo, Asier Antoranz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanomaLuca Di Leo, Chiara Pagliuca, Ali Kishk, et al.
Nature Communications|September 6, 2024
Hyper-recombination in ribosomal DNA is driven by long-range resection-independent RAD51 accumulationZita Gál, Stavroula Boukoura, Kezia Catharina Oxe, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2025
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibitionMie K Jakobsen, Sofie Traynor, Aaraby Y Nielsen, et al.
Nature Communications|May 6, 2021
Loss of Ambra1 promotes melanoma growth and invasionLuca Di Leo, Valérie Bodemeyer, Francesca M Bosisio, et al.
Molecular & Cellular Proteomics : MCP|July 2, 2003
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer researchJulio E Celis, Pavel Gromov, Irina Gromova, et al.
Human Mutation|March 26, 2003
Genetic diversity within the R408W phenylketonuria mutation lineages in EuropeOrna Tighe, Donncha Dunican, Charles O'Neill, et al.
Pageof 11